1991 (landmark Italian trial): A double-blind, placebo-controlled trial involving 130 patients with Alzheimer's disease demonstrated that one year of ALCAR treatment resulted in a slower rate of deterioration compared to placebo across 13 of 14 outcome measures, including significant improvements in the Blessed Dementia Scale, logical intelligence, verbal critical abilities, long-term verbal memory, and selective attention [5][17]
Clinical trials and scoping reviews show promising signalsimproved quality of life and symptom control in some patientsthough larger confirmatory trials are still emerging
Schedule a consultation at one of Vancouvers top clinics today and take the first step toward radiant health and beauty!
With so many unhealthy energy drinks dominating store shelves, its no surprise theyve earned a bad reputation
Dosing Schedules: Where the Confusion Starts Same medication, different intent, different dose ceilings, and different end goals